Risk of fatal ICH with alteplase for stroke (id = "example-stroke-alteplase-fatalICH")
<?xml version="1.0" encoding="UTF-8"?>
<Evidence xmlns="http://hl7.org/fhir">
<id value="example-stroke-alteplase-fatalICH"/>
<text>
<status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml">
<p>
"Risk of fatal ICH with alteplase for stroke" is a univariate
risk estimate.
</p>
</div>
</text>
<extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg">
<valueCode value="cds"/>
</extension>
<url value="http://hl7.org/fhir/Evidence/example-stroke-alteplase-fatalICH"/>
<identifier>
<system value="urn:ietf:rfc:3986"/>
<value value="urn:oid:2.16.840.1.113883.4.642.10.1"/>
</identifier>
<name value="RiskOfFatalICHWithAlteplaseForStroke"/>
<title value="Risk of fatal ICH with alteplase for stroke"/>
<status value="draft"/>
<publisher value="HL7 International / Clinical Decision Support"/>
<contact>
<telecom>
<system value="url"/>
<value value="http://www.hl7.org/Special/committees/dss"/>
</telecom>
</contact>
<relatedArtifact>
<type value="citation"/>
<label value="Emberson 2014"/>
<display value="Effect of treatment delay, age, and stroke severity on the effects of intravenous
thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual
patient data from randomised trials."/>
<citation value="Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, et al;Stroke Thrombolysis
Trialists' Collaborative Group. Effect of treatment delay, age, and stroke severity
on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke:
a meta-analysis of individual patient data from randomised trials. Lancet 2014
Nov 29;384(9958):1929-35 PMID 25106063"/>
<document>
<url value="https://doi.org/10.1016/S0140-6736(14)60584-5"/>
</document>
</relatedArtifact>
<description value="2.7% incidence of fatal intracranial hemorrhage within 7 days with alteplase in
patients with acute ischemic stroke"/>
<variableDefinition>
<variableRole value="population"/>
<observed>
<reference value="Group/Emberson-2014-IPD-MA-Alteplase-Cohort"/>
<type value="Group"/>
<display value="Emberson 2014 IPD-MA Alteplase Cohort"/>
</observed>
<intended>
<reference value="Group/AcuteIschemicStrokeTreatedWithAlteplase"/>
<type value="Group"/>
<display value="adults with acute ischemic stroke treated with alteplase"/>
</intended>
</variableDefinition>
<variableDefinition>
<variableRole value="outcome"/>
<observed>
<reference value="EvidenceVariable/example-fatal-ICH-in-7-days"/>
<type value="EvidenceVariable"/>
<display value="fatal ICH"/>
</observed>
<intended>
<reference value="EvidenceVariable/example-fatal-ICH-in-7-days"/>
<type value="EvidenceVariable"/>
<display value="fatal ICH"/>
</intended>
</variableDefinition>
<synthesisType>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/synthesis-type"/>
<code value="IPD-MA"/>
<display value="individual patient data meta-analysis"/>
</coding>
</synthesisType>
<studyDesign>
<coding>
<system value="http://hl7.org/fhir/study-design"/>
<code value="SEVCO:01003"/>
<display value="randomized assignment"/>
</coding>
</studyDesign>
<statistic>
<statisticType>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/statistic-type"/>
<code value="C44256"/>
<display value="Proportion"/>
</coding>
</statisticType>
<quantity>
<value value="0.026835741669"/>
</quantity>
<numberOfEvents value="91"/>
<sampleSize>
<numberOfStudies value="9"/>
<numberOfParticipants value="3391"/>
</sampleSize>
</statistic>
</Evidence>
Usage note: every effort has been made to ensure that the
examples are correct and useful, but they are not a normative part
of the specification.